Zymergen vs Pow.bio

Zymergen was an Emeryville machine-learning-driven biomanufacturing company; after its lead bio-electronics film Hyaline flopped post-IPO, it was sold to Ginkgo Bioworks in 2022 and wound down.

Biotech

Pow.bio

Pow.bio offers continuous-fermentation technology and contract manufacturing (CDMO) services aimed at cutting the cost of biomanufactured products.

For subscribers

Subscribe for the full comparison

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →